glp 1 for type 1 diabetes Scripts GLP-1, SGLT2 Drugs on the Rise in Patients Weight-Loss Drug Use Has Risen

While GLP1s have been around almost 20 years, initially approved as a treatment for type 2 diabetes, theyve recently been catapulted into the public domain due to their demonstrated effectiveness as a weight loss agent

Editor's note: This blog was revised to include updated information on May 29, 2025

Similarly, as a result of the positive findings from the recent DAPA-CKD trial [90], dapagliflozin is now indicated for the treatment of CKD, and can be initiated if eGFR 25 ml/min/1.73 m 2

Individualised assessment by gastroenterology and diabetes specialists is essential

Clinical Pharmacology (12.3).] In the event of an overdose with JANUVIA, contact the Poison Control Center